MEDVIA is one of the founding partners of the InnoMedCatalyst project. Launched in 2024, this ambitious European initiative is designed to enhance the regional innovation capacity in precision and personalized medicine, with a specific focus on 5P Medicine: predictive, preventive, personalized, participatory and precise.

This collaborative project brings together innovators, startups, scaleups and healthcare providers to accelerate the development and implementation of groundbreaking digital health solutions that will shape the future of healthcare across Europe.

Ambitious plans for the next few years

The InnoMedCatalyst project is set to revolutionize the 5P Medicine ecosystem by boosting the capabilities of various stakeholders to develop, test and refine digital health solutions. The initiative aims to catalyze open innovation and bridge the gap between medtech companies and healthcare providers, making Europe a global leader in precision and personalized medicine.

Key objectives for the project include:

• Mapping Regional Value Chains: Analyzing and visualizing current activities, processes and stakeholders in 5P digital medicine, creating 10 regional maps that identify key players and their roles
• Enhancing Innovation Capacity: Facilitating over 25 collaborative activities, including cross-regional workshops, tailored training programs, twinnings, demo days and learning missions aimed at improving healthcare systems and patient outcomes
• Creating an Innovation Ecosystem: By implementing dedicated acceleration and mentorship programs, InnoMedCatalyst will support 36 startups, spinoffs and entrepreneurs in developing digital medicine solutions
• Fostering Open Innovation: Through an Open Innovation Network Platform, the project will connect medtech companies with healthcare providers, allowing for the “test before invest” of 5P medicine solutions, supported by two online B2B brokerage events
• Developing Interregional Investment Projects: By 2026, the project aims to generate at least 20 investment-ready projects in precision medicine

International Consortium Partners

InnoMedCatalyst is spearheaded by ADR Nord-Est (Romania), alongside an outstanding consortium of partners from across Europe:

• ADR Nord-Est, RO – Coordinator
• MEDVIA, BE
• Clusterul Imago-Mol, RO
• Life Science Klaster Krakow, PL
• Health and Life Sciences Cluster, BG
• CLUST-ER Health Emilia Romagna, IT
• SIVI Cluster, ES
• BIOCAT, ES
• Hellenic BioCluster, GR
• Health Cluster Portugal, PT
• Startup Madeira, PT
• EUREGHA, BE
• InPulsePartners, RO

Help shape the future of 5P medicine & digital innovation – Take part in our survey!

Are you working on innovative healthcare solutions? We invite you to participate in our InnoMedCatalyst survey to help shape future innovation projects focused on 5P medicine and its digital applications.

By taking part, you will:
✔ Help identify key needs and opportunities in the field
✔ Gain access to future innovation projects with higher TRLs
✔ Stay informed about potential funding opportunities within the project

🔗 Fill out the survey here

Please fill out the survey by 18 April.

Additionally, if you are open to sharing deeper insights, we offer the opportunity for a one-on-one interview with our team. Please contact Ines Verbaendert or Johan Lecocq

Your input is invaluable in driving impactful innovations.

Thank you for your support!